JMP Securities Initiates Coverage On Jasper Therapeutics with Market Outperform Rating, Announces Price Target of $70
Portfolio Pulse from Benzinga Newsdesk
JMP Securities has initiated coverage on Jasper Therapeutics with a Market Outperform rating and set a price target of $70.

September 09, 2024 | 10:02 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
JMP Securities has initiated coverage on Jasper Therapeutics with a Market Outperform rating and a price target of $70, indicating a positive outlook.
The initiation of coverage with a Market Outperform rating and a high price target suggests a strong positive sentiment from JMP Securities, likely boosting investor confidence and potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100